html5-img
1 / 38

INTENTIONAL THALLIUM POISONING – VERIFICATION AND TREATMENT

INTENTIONAL THALLIUM POISONING – VERIFICATION AND TREATMENT. Pelclová D (1), Šenholdová Z (1), Lukáš E (1), Urban P (2), Lacina L (3), Vlček K (1), Fenclová Z (1), Kitzlerová, E (4). 1. Department of Occupational Medicine, Charles University, Prague

tiana
Download Presentation

INTENTIONAL THALLIUM POISONING – VERIFICATION AND TREATMENT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. INTENTIONAL THALLIUM POISONING – VERIFICATION AND TREATMENT Pelclová D (1), Šenholdová Z (1), Lukáš E (1), Urban P (2), Lacina L (3), Vlček K (1), Fenclová Z (1), Kitzlerová, E (4). 1. Department of Occupational Medicine, Charles University, Prague 2. National Institute of Public Health, Prague 3. Department of Dermatology; 4. Psychiatric Department, General University Hospital and First Medical faculty, Charles University, Prague, Czech Republic

  2. THALLIUM • discovered in 1861 by Sir Williams Crooks • 1862 by French chemist Claude-Auguste Lamy • In Greek, thallos "green twig." • Using spectroscopy, the brightest lines in the spectrum of thallium are green • melting point 300º C (576º F) • boiling point 1480º C (2,655º F) • elementary thallium non-toxic • monovalent and threevalent salts very toxic • LD about 900 mg

  3. THALLIUM • rather uncommon element • world production 12tons/year semiconductors, photocells, optic glass, thermometers • in medicine – Tl201radioactive tracer in heart scintigraphy to detect myocardial ischaemia • occurrence in minerals • emissions 1500 tons/year granite, coal

  4. THALLIUM – IN THE PAST • Tl2SO4 has long been used as rodenticide, insecticide • Colorless and tasteless • Tl acetate : treatment of • veneric diseases,ringworm • Depilatory agent • Low therapeutic index • Banned in the 1970ies in most countries

  5. Toxicokinetics – inorganic salts • absorption by all ways, oral about 90% • distribution to all tissues • greatest concentration in the intestines, liver, kidney, heart, brain and muscles • excretion by faeces and urine, • the proportion 2:1 • enterohepatic circulation • half-lives 1-30 days

  6. Pathophysiology - 1 • Similarities in charge and ionic radius between K+ and Tl+ ions), Tl substitutes for K: • 1. blocks energyutilizationbyNa-K-ATPasechannel = (active transport of monovalent ions - K+ across cell membrane) Thallium disturbs maintaining of a resting potential across the membrane of active cells - Tl has 10-fold greater affinity. Neuronal, cardiac and skeletal muscle cells • 2. blocks energyproduction from glucose: ADP to ATP by pyruvate kinase = K requiring enzyme - links anaerobic glycolysis to the Krebs cycle) inhibition by binding with 50-fold affinity comparing to K.

  7. Pathophysiology - 2 • 3. damages riboflavin, precursor of FAD forming an insoluble complex and intracellular sequestration of vit. B6 decrease of riboflavin disrupts metabolism by reducing activity of Krebs cycle • 4. binds to SH groups and interferes with formation of disulphide bonds in keratin - structural damage to hair, nails • 5. causes activation or inhibition of other enzymes (ALA synthetase, B12 metabolism…)

  8. 2 Case reports • 2 patients, mother and daughter, living in the same household • Very probably intentional poisoning by one member of the family • Oral intake • Chronic

  9. Patient Amother • 44years old • PH: no serious disease • OH: super-market manager • 1. poisoning • November 2004 sudden strong chest pain, following 3 days severe pain with paresthesias in both lower limbs • Symptoms disappeared within 3 weeks, following 3 weeks persisted mild paresthesias and discomfort in the lower limbs

  10. 2. poisoning • In March 2005 she developed suddenly a strong muscular pain in the lower limbs. The gait was painful „as on a broken glass“. • within 5 days she became bald. • In April – one month stayed at neurology dept. With suspicion on LI syndrome and posttraumatic stress disorder (anxious, depressive, had work overload and home conflict environment) • EMG, evoked potentials, MRI normal • In June improvement, returned to work

  11. 3. poisoning • August 2005 • Progressive pain in lower limbs with paresthesias • Blurred vision – she could differentiate only dark and light spots in the periphery of the visual field • After 3 weeks her condition improved a little • Mild pain in the feet and knees persisted several weeks • Vision difficulties persisted • Eye fundus : n. opticus atrophy

  12. HospitalizationDept. Occupat. Medicine • Admitted on January 31,2006 • 5 months after last intoxication • 1) attempt to prove the poisoning • 2) attempt to improve vision damage – she still could not read EMG: mild motor and sensoric damage, EEG borderline Visual evoked potentials: severe damage with visus • BIOLOGICAL HALF-LIFE of thallium • broad range of 1-30 daysHoffman RS. Toxicol Rev 2003

  13. Patient B: Historydaughter • 22years old woman • PH: no serious disease • OH: high school,1 year maternity leave • FH: mothertreated for symptoms of unknown etiology, father probably psychopathic personality, no treatment, daughter 1 year old, healthy

  14. 1 poisoning • In December 2005 suddenly strong pain in lower limbs, maximum in the stockings distribution, ache in the skin of lower extremities • Anorexia • 3rd week symptoms deteriorated, treated with analgesics (tramadol) • 4th week lost all body hair (except eyebrow and eyelashes) • She developed blurred vision, weakness of lower limbs, unable to walk • Hospitalized at neurology dept.

  15. Hospitalization at Neurology Dept. • Blood and urine sent to toxicology screening (drugs, metals incl. Cd, Pb, Hg, Se, Zn, Tl,) • 5th week: vision damage with maximum in the central area, right and left eye • Shortly also speaking difficulties and feeling of heavy tongue • Positive results for thallium in blood and urine

  16. Hospitalization atDept. Occup. Medicine • Admitted on January 26, 2006 • 7th week of symptoms • On admission: • On a wheel chair, paraparesis, motor weakness • Bald (only eyebrow and lashes left) • Could distinguished fingers from 30 cm complained of strong pain in lower limbs • Altered mental status, depressive, anxious • Slow speech, low voice

  17. Antidote • Prussian blue - Fe4[Fe(CN)6]3 (ferric hexacyanoferrate), • Radiogardase, Heyl • CAS 14038-43-8 • discovered 1704 by a Berlin color maker Diesbach • since the 1960s used to treat Cs and Tl poisonings • Binds thallium by ion exchange, adsorption and mechanical trapping within the crystal structure

  18. Specific treatment • Insoluble, low absorption from the GIT (?) • stops enterohepatic circulation of thallium • Increases elimination both to faeces and urine • Advantage: rare side effects, bluish sweat and tears • Reduces half-life from 8 to 3 days • First dose after arrival 6g /12 hours • Continued with 12 g/day in 4 doses

  19. Supportive therapy • 10% mannitol as cathartic • Charcoal (Carbosorb) 2x 25 g/day • Analgesics • Vit. B12, B6 • Topical dermatological treatment supporting hair growth

  20. Thallium concentration in urine µg/lin the daughterTotal excretion 8.4 mg in 32 days, further Tl in faecesAntidotal treatment 22 days

  21. Toxicological analysis in daughter • Thallium found in all biological materials – blood, urine, faeces, hair

  22. Examinations • Neurological (incl. needle EMG, VEP, BAEP, EEG,MRI of the brain) • Ophthalmological (visus, fundus, perimeter) • Dermatological • Further: • ECG, psychiatric,blood biochemical analysis, urinalysis, kidney functions

  23. January 20052nd month • Unable to walk • Severe polyneuropathy • Verified by needle EMG • sensory, motoric and autonomic • Symmetrical • Low extremities only

  24. April 20065th month • Able to walk with a walker leg support. • Severe motor polyneuropatie. Mild improvement, esp. Sensitive and autonomic nerves. • MRI of the brain:normal finding incl. optic nerves, tracts, chiasma and visual cortex • Atrophy of both optic nerves on the ocular fundus

  25. August 20069th month • Still severe motor polyneuropathy • She could walk without support • Unstable gait • Pathology in EEG, VEP, BAEP • Vision of fingers from 0.75 m

  26. Slightly abnormal entrance findings Control: slow improvement 2nd month: no response due to severe vision damage 5th month: Low peak at right side, no response left side. 9th month: Bilaterally abnormal finding low reproducibility and low VEP, worse left side EEG, BAEP VEP

  27. FURTHER FINDINGS • ECG – non-specific ST segment and T wave changes during a febrile state with tachycardia • Transthoracic echocardiography – diffuse hypokinesis of the left ventricle, markers normal • Psychiatric examination • Neuropsychological testing not possible – visual problems • USG of the abdomen normal • Kidney functions normal

  28. Total alopeciadaughter • Reversible • Highest value 36.1 μg/g (5thweek) • Sequential analysis of 1.5 cm hair segments = 6 months • Thallium 5.61- 6.24 – 7.41 – 7.81 – 6.67 μg/g hair • New hair 6thweek of poisoning and 8thday of antidote treatment– drop to 1.6 μg/g)Daniel J Am Acad Dermatol 2004

  29. Trichological analysis of the acute hair loss of the daughter Normal hair • Light microscopy - • The proximal end hair fibre tapered and distorted.  • Rough surface of the proximal end • Amorphous cuticular and cortical cells as a sign of the pathological keratinisation. (Metter and Vock 1984)

  30. Trichological analysis of the acute hair loss of the daughter • Under transmitted-light microscopy the cortex dark discolorisation and disorganized on the widened club-shaped end. • Gaseous inclusions under the phase contrast microscopy.

  31. Trichological analysis of the new hair of the mother • Hair of the acute loss not available • Recent hair – normal finding, smooth surface of keratinocytes

  32. Thallium in urine (μg/l)Optical Emission Spectrometer - Inductively Coupled Plasma (OES-ICP)

  33. Thallium in urine (μg/l)voltammetry

  34. Thallium in blood and faecesOptical Emission Spectrometer - Inductively Coupled Plasma (OES-ICP)

  35. CONCLUSION - mother • Treatment with Prussian blue produced a higher excretion of thallium in urine • And a measurable amount in faeces • In mother the clinical effect was negligible – • 1¼ year after last poisoning: • EMG: Residual mild axonal sensory neuropathy, mild improvement after 6 months. Autonomic fibers without damage. • Opthalmologic examination: scotomas of upper and central parts of both visual fields • Visual evoked potentials: prologed latency, lower amplitude

  36. CONCLUSION - daughter • 1 year after intoxication • EMG examination - Severe damage in motor and sensory fibers, autonomic normalized already • Ophthalmologic examination – mild improvement • right eye - scotomas in central and medium periphery • left eye – scotomas in central area

  37. SUMMARY • Thallium typically causes damage of peripheral nerves of lower extremities, vision and hair. • Combination of these symptoms suggests thallium poisoning • Late treatment has low effect • Prognosis of hair loss is good • Polyneuropathy improves within months till years • Vision damage has the worst prognosis

  38. THANK YOU • 3rd victim – dog of the family

More Related